written on 30.04.2014

Rise in patient reporting boosts EU drug safety signals

TAGS: ,

The introduction of direct reporting of adverse drug reactions by patients in Europe appears to have had the desired effect: in 2013, the number of ADRs reported by patients within the European Economic Area (EEA) rose by more than 50% as a result of…